NEW YORK, May 12 (GenomeWeb News) - 454 Life Sciences has signed an exclusive distribution agreement with Roche for its sequencing technology in a deal potentially worth $62 million to the sequencing upstart. 454 has also named a new chief executive as CuraGen Jonathan Rothberg has stepped down.
...and receive Daily News bulletins.
Already have an account?Login Now.
Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.
Genetic genealogy has led to an arrest in another cold case, dating back to 1987.
Wired reports that 23andMe is trying to bolster its outside collaborations.
In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.